JP

John Pacifico

President, Chief Executive Officer, and Board Member of Abyrx, Inc. | General Partner at Canaan Partners | Founder and Chairman of Kairuku, Inc.

New York City Metropolitan Area

Invests in

Stages:

Sectors:

Health & Hospital Services

Locations:

Westport, Connecticut

Min Investment:
$250,000.00
Max Investment:
$20,000,000.00
Target Investment:
$10,000,000.00

Skills

Medical Devices

Pharmaceutical Industry

Business Development

Venture Capital

Mergers & Acquisitions

Commercialization

Entrepreneurship

Business Strategy

Education

Kauffman Fellow
(2007 - 2009)
MBA
Columbia University
(2006 - 2007)
Bachelors of Science & Varsity Baseball
Charles F. Dolan School of Business at Fairfield University

Lists including John

Based in NYC

2600 people

All Seed Investors

19695 people

Investments

Aceiss

Total Funding: $3M

Work Experience

2018

General Partner
2018
Early-stage venture capital investment firm.

2013

President, Chief Executive Officer, and Member of the Board of Directors
2013
Developer of biosurgical technologies.

2013

Founder and Chairman
2013
SaaS solution to optimize distribution of medical products and information share.

PrimeFour Therapeutics

2021

Board Member
2021
Developing new pharmaceuticals to treat cancers.

Transposon Therapeutics

2020

Board Member
2020
Developing new pharmaceuticals to treat neurodegenerative disorders.

2021

Board Member
2021
Cybersecurity company enabling continuous / real-time visibility and insights into user access across enterprise technology systems.

2007 - 2013

President, Chief Executive Officer, and Member of the Board of Directors
2007 - 2013
Targeted drug delivery products for use during surgical procedures.

2000 - 2007

Venture Capitalist
2000 - 2007
Early-stage venture capital investment firm.